期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 139, 期 16, 页码 5684-5687出版社
AMER CHEMICAL SOC
DOI: 10.1021/jacs.7b01705
关键词
-
资金
- National Science Foundation [DGE-1111169]
- Amgen
- Shionogi Co., Ltd.
- NIH [NIGMS R35GM118191-01, GM111805-01]
An asymmetric Ni-catalyzed reductive cross-coupling of (hetero)aryl iodides and benzylic chlorides has been developed to prepare enantioenriched 1,1-diarylalkanes. As part of these studies, a new chiral bioxazoline ligand, 4-heptyl-BiOX (L1), was developed in order to obtain products in synthetically useful yield and enantioselectivity. The reaction tolerates a variety of heterocyclic coupling partners, including pyridines, pyrimidines, indoles, and piperidines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据